Clinical outcomes of septal myectomy in hypertrophic cardiomyopathy with refractory symptoms: A single institutional experience from India

被引:0
|
作者
Maramreddy, Revanth [1 ,4 ]
Bahl, Ajay [2 ]
Tingnam, Shyam Kumar Singh [3 ]
机构
[1] Kasturba Med Coll & Hosp, Dept Cardiothorac Surg, Manipal, India
[2] PGIMER, Dept Cardiol, Chandigarh, India
[3] PGIMER, Dept Cardiothorac Surg, Chandigarh, India
[4] 1001B, Udupi 576104, Karnataka, India
来源
CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH | 2023年 / 24卷
关键词
Hypertrophic cardiomyopathy; Left ventricular outflow tract; Mitral regurgitation; Systolic anterior motion; MITRAL REGURGITATION; OBSTRUCTIVE CARDIOMYOPATHY; RELIEF;
D O I
10.1016/j.cegh.2023.101408
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Myectomy is the surgical procedure for the treatment of hypertrophic cardiomyopathy (HCM) with refractory symptoms There is limited data available regarding the role of myectomy in HCM among the Indian population. This study is intended to assess the outcomes of myectomy in HCM.Methods: Change in the gradient across the left ventricular outflow tract and severity of mitral regurgitation after myectomy were studied using echocardiography. Functional status, exercise tolerance, and cardiac rhythm of the patients were studied before and after myectomy.Results: The study consists of eleven patients with HCM. Four patients were in NYHA grade II, seven were in NYHA grade III before surgery. After surgery nine were in NYHA grade I and two were in NYHA grade II. Exercise tolerance of the study group was in the range of 1 min before surgery and it improved to 6.27 min after surgery. LVOT gradient before surgery was 108.81 and 112.45 mm of Hg on TTE and TEE respectively and it was 17.9 and 15.63 mm of Hg on TEE and TTE respectively after myectomy. On TTE eight patients had severe MR and three had moderate MR before surgery, while nine of them had severe MR and two had moderate MR on TEE. In the immediate post-operative period nine had mild MR, one had moderate MR, whereas the remaining one patient underwent MVR. TTE at six months revealed mild MR in seven, moderate MR in two patients and one had no MR.Conclusions: Surgical septal myectomy is an effective treatment modality for obstructive HCM.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Is there referral bias in outcomes of septal myectomy for hypertrophic cardiomyopathy?
    Calderon-Rojas, Rolando
    Nguyen, Anita
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Ommen, Steve R.
    King, Katherine S.
    Lee, Alexander T.
    Dearani, Joseph A.
    Schaff, Hartzell, V
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03) : 881 - 891
  • [2] Transapical septal myectomy for hypertrophic cardiomyopathy, an experience from Japan
    Shimizu, Atsushi
    Takanashi, Shuichiro
    Takamisawa, Itaru
    Shimokawa, Tomoki
    Takayama, Morimasa
    Isobe, Mitsuaki
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2022, 30 (01) : 108 - 114
  • [3] Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy
    Fernandez, Rafle
    Nappi, Francesco
    Horvath, Sofia A.
    Guigui, Sarah A.
    Mihos, Christos G.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 983 - 990
  • [4] Surgical Septal Myectomy for Hypertrophic Cardiomyopathy in Greece: A Single-Center Initial Experience
    Efthimiadis, Georgios K.
    Pitsis, Antonis
    Pagourelias, Efstathios D.
    Kamperidis, Vasileios
    Kelpis, Timotheos
    Meditskou, Soultana
    Hadjimiltiades, Stavros
    Ninios, Vlassios
    Mezilis, Nikolaos
    Maron, Barry J.
    Styliadis, Ioannis H.
    HELLENIC JOURNAL OF CARDIOLOGY, 2014, 55 (02) : 132 - 138
  • [5] Outcomes after septal myectomy in a cohort of patients with hypertrophic cardiomyopathy
    Lopez-Gutierrez, L., V
    Orozco-Burbano, J. D.
    Murillo-Moreno, M. A.
    Durango-Gutierrez, L. F.
    Hernandez-Aramburo, P. M.
    Gonzalez-Franco, S. G.
    Arenas, E. M. Canas
    Rendon-Isaza, J. C.
    Saldarriaga-Giraldo, Ci
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (09)
  • [6] A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy
    Iacovoni, Attilio
    Spirito, Paolo
    Simon, Caterina
    Iascone, Maria
    Di Dedda, Giovanni
    De Filippo, Paolo
    Pentiricci, Samuele
    Boni, Luca
    Senni, Michele
    Gavazzi, Antonello
    Ferrazzi, Paolo
    EUROPEAN HEART JOURNAL, 2012, 33 (16) : 2080 - 2087
  • [7] Surgical Septal Myectomy for Hypertrophic cardiomyopathy. The Iranian Experience
    Ghavidel, Alireza Alizadeh
    Alizadehasl, Azin
    Khalilipur, Ehsan
    Amirghofran, Ahmadali
    Nezhadbahram, Hanieh
    Azarfarin, Rasoul
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2022, 30 (01) : 64 - 73
  • [8] Impact of Hospital Volume on Outcomes of Septal Myectomy for Hypertrophic Cardiomyopathy
    Holst, Kimberly A.
    Schaff, Hartzell V.
    Smedira, Nicholas G.
    Habermann, Elizabeth B.
    Day, Courtney N.
    Badhwar, Vinay
    Takayama, Hiroo
    McCarthy, Patrick M.
    Dearani, Joseph A.
    ANNALS OF THORACIC SURGERY, 2022, 114 (06) : 2131 - 2138
  • [9] Latent outflow tract obstruction in hypertrophic cardiomyopathy: Clinical characteristics and outcomes of septal myectomy
    Cui, Hao
    Schaff, Hartzell, V
    Nishimura, Rick A.
    Dearani, Joseph A.
    Geske, Jeffrey B.
    Ommen, Steve R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (06) : 1863 - +
  • [10] Extended Myectomy for Hypertrophic Cardiomyopathy: Early Outcomes From a Nascent Centre of Excellence in Canada
    Crean, Andrew M.
    Gharibeh, Lara
    Saleem, Zain
    Glineur, David
    Maharaj, Gyaandeo
    Grau, Juan B.
    CJC OPEN, 2022, 4 (11) : 921 - 928